# Use of New MolEcular MarkErs for a persoNalized Therapy in Ovarian Cancer-MEMENTO

> **NCT06917469** · — · COMPLETED · sponsor: **Centro di Riferimento Oncologico - Aviano** · enrollment: 140 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06917469
- **Lead sponsor:** Centro di Riferimento Oncologico - Aviano
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-20
- **Primary completion:** 2022-06-20
- **Final completion:** 2022-06-20
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06917469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06917469, "Use of New MolEcular MarkErs for a persoNalized Therapy in Ovarian Cancer-MEMENTO". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06917469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*